You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 280 No. 2, July 8, 1998 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Contempo 1998: Updates Linking Evidence and Experience
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (5)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Men's Health
 •Prostate Disease
 •Oncology
 •Colon Cancer
 •Prostate Cancer
 •Surgery
 •Surgical Interventions
 •Colorectal Surgery
 •Gastroenterology
 •Gastrointestinal Diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Detection of Prostate and Colon Cancer

Scott Stern, MD; Diane Altkorn, MD; Wendy Levinson, MD

JAMA. 1998;280:117-118.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

INTRODUCTION

CANCER DETECTION continues to be an important focus of primary care. Many groups, including the American Cancer Society and the US Preventive Services Task Force, periodically publish recommendations for cancer screening. As new information becomes available, these recommendations need reevaluation and revision. In this article, we review recent studies that have modified our approach to the detection of prostate cancer and colorectal cancer.


Prostate Cancer

Screening for prostate cancer by serum prostate-specific antigen (PSA) measurement continues to generate controversy. PSA testing is recommended by the American Cancer Society1 but not by the US Preventive Services Task Force.2 Critics of PSA screening raise several concerns. First, there have been no randomized trials showing that the detection of prostate cancer by PSA screening decreases prostate cancer–associated morbidity or mortality. Second, autopsy studies suggest that 30% of men have indolent tumors that develop late in life . . . [Full Text of this Article]

Colon Cancer

From the Department of Medicine, University of Chicago, Chicago, Ill.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Talking With Patients About Screening for Prostate Cancer
Rosenthal et al.
JAMA 1999;281:133-133.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1998 American Medical Association. All Rights Reserved.